ACORN CAPITAL ADVISORS, LLC
CIK: 0002054410SEC EDGAR →
Portfolio Value
$295.1B
Holdings
21
As of
Q4 2025
New Positions
1
Closed Positions
1
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | 1,746,264 | $70.5B | 23.90% |
| 2 | CG ONCOLOGY INC | 1,131,501 | $47.0B | 15.92% |
| 3 | UROGEN PHARMA LTD | 1,448,420 | $33.9B | 11.49% |
| 4 | TREVI THERAPEUTICS INC | 2,144,844 | $26.9B | 9.10% |
| 5 | PUMA BIOTECHNOLOGY INC | 4,131,299 | $24.6B | 8.33% |
| 6 | CANDEL THERAPEUTICS INC | 2,580,517 | $14.6B | 4.94% |
| 7 | CYBIN INC | 1,573,023 | $12.9B | 4.36% |
| 8 | VERASTEM INC | 1,469,153 | $11.3B | 3.84% |
| 9 | BICARA THERAPEUTICS | 643,382 | $10.8B | 3.67% |
| 10 | PROTARA THERAPEUTICS INC | 1,752,115 | $9.3B | 3.16% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 20 | $294.0B | 99.6% |
| Unknown | 1 | $1.1B | 0.4% |